We have examined the effect of depleting microglia during the early stage of disease by using PLX, an inhibitor of colony-stimulating factor 1 receptor (CSFR1), on disease severity in a mouse model of SCA1. The gene discussed is CSF1R; the disease is spinocerebellar ataxia type 1.